Astera Labs (ALAB) Jumps 13% as Big Tech Doubles Down on Its AI Chips

TLDR

• Astera Labs (ALAB) opened at $134.73 after a prior close of $129.46, and last traded around $145.30 — a gain of roughly 13% on the day.
• The Ultra Accelerator Link Consortium ratified updated UALink specifications, adding In-Network Compute and boosting demand for Astera’s open-standard AI interconnects.
• Two more major hyperscalers adopted the Scorpio P-Series for new AI platforms, extending the company’s customer momentum.
• Q4 earnings beat estimates: EPS of $0.58 vs. $0.51 expected, and revenue of $270.6M — up 91.8% year-over-year.
• Analyst consensus sits at “Moderate Buy” with an average price target of $199.44, well above today’s trading price.

Astera Labs had a strong Friday on the markets. The stock gapped up at the open and pushed well into the mid-$140s — a move of over 13% — driven by a combination of industry news, customer wins, and a solid earnings backdrop.

Astera Labs, Inc. Common Stock, ALAB

The clearest catalyst was a standards update. The Ultra Accelerator Link Consortium ratified new UALink specifications, which now include In-Network Compute functionality. For Astera, this is meaningful. The company has positioned itself as a key player in open-standard AI interconnects, and the UALink update reinforces that bet. Investors read it as validation that Astera’s technology will sit at the center of next-generation data center infrastructure.

The second driver was customer news. Two additional major hyperscalers announced they are adopting Astera’s Scorpio P-Series for new AI platforms. That adds to a growing list of large-scale deployments and suggests demand is broadening beyond early adopters.

Strong Earnings Still Doing Heavy Lifting

None of this would carry as much weight without the earnings story behind it. In February, Astera reported Q4 results that beat on both the top and bottom lines. EPS came in at $0.58 against a consensus estimate of $0.51. Revenue hit $270.58 million, above the $249.46 million analysts had expected — and up 91.8% compared to the same period last year.

The company guided Q1 2026 EPS in the range of $0.530 to $0.540. Net margin stood at 25.70% and return on equity at 16.12%.

With a market cap of around $25 billion, the stock carries a P/E of 119.54 — a premium multiple that reflects high growth expectations. The 200-day moving average sits at $156.21, above today’s price, meaning the stock is still recovering from a pullback that began earlier this year. Year-to-date, ALAB is down about 22% before today’s move.

What Analysts Are Saying

Analyst sentiment is broadly constructive. Of the 22 analysts covering the stock, 15 have Buy ratings, six have Hold, and one has a Sell. The average price target is $199.44 — a significant premium to where the stock is trading today.

Recent initiations include Citigroup, which started coverage on April 2nd with a Buy and a $200 price target, and Loop Capital, which came in on March 5th with a Buy and a $250 target. Royal Bank of Canada set an Outperform with a $225 target in January. Barclays has a $165 target, while Weiss Ratings cut to Sell in February.

On the insider side, CEO Jitendra Mohan sold 157,500 units of stock on March 17th at an average price of $131.58. General Counsel Philip Mazzara sold 10,000 units on April 1st at $107.77 under a pre-arranged Rule 10b5-1 plan. In total, insiders sold around 577,000 units worth roughly $69.5 million over the past 90 days. Insiders currently own 12.50% of the company.

Institutional ownership sits at 60.47%. Vanguard increased its position by 14.1% in Q3, while Atreides Management grew its holding by over 2,400% in Q4.

The 50-day moving average is $128.14.

The post Astera Labs (ALAB) Jumps 13% as Big Tech Doubles Down on Its AI Chips appeared first on CoinCentral.